证券日报网3月20日讯 ，奥比中光在接受调研者提问时表示，据了解，物理AI的目标是让智能体可以理 解真实世界的运行规律，自主地感知、理解并执行复杂操作，从而进行有效交互；而世界基础模型是理 解现实世界动态（包括其物理和空间属性）的生成式AI模型。各类AI端侧硬件通过学习，在理解现实 环境物理特性的前提下，对运动以及感知数据中的空间关系等动态进行表征和预测，实现自主交互。基 于对物理AI和世界基础模型的理解，NVIDIA已经推出多款工具类产品，用于智能驾驶、机器人训练及 工业数字孪生的开发，如NVIDIACosmos、NVIDIAOmniverse、NVIDIAIsaacSim等。 公司的3D视觉感知技术能够精准捕捉三维空间信息，结合自研算法，为各类AI智能终端赋予环境感 知、智能交互、动态导航等核心能力。作为NVIDIA全球产业数字化生态布局的合作伙伴之一，公司持 续与NVIDIAOmniverse生态深入融合并将更多视觉生态产品融入到NVIDIA平台中。如公司Gemini335、 Gemini336系列双目3D相机，已入驻NVIDIAIsaacSim机器人仿真开发平台，并与NVIDIAIsaacPercep ...

Investment Rating - The report assigns an "Overweight" rating for the industry, indicating a projected performance that exceeds the Shanghai and Shenzhen 300 Index by more than 15% [11]. Core Insights - In 2026, NVIDIA's advancements in embodied intelligence have transitioned from technical exploration to engineering implementation and ecosystem development, focusing on software models, simulation infrastructure, hardware deployment, and collaborative ecosystems [2][4]. - The humanoid robot industry is entering the "engineering implementation" phase, with significant investment opportunities identified in both beta (software and embodied models) and alpha (hardware) categories [4]. Summary by Relevant Sections Investment Recommendations - The report suggests focusing on: 1. Beta opportunities in embodied models and software, recommending companies such as Hangcha Group, UBTECH, and Woan Robotics. 2. Alpha opportunities in hardware, including: - Force/Torque sensors: Anpeilong - Encoders: Yapu Co., Ltd., Shuo Beid - Visual sensors: Aoptical, Orbbec - IMU: Joyson Electronics, Huayi Technology - Power devices: Innodisk - MCU and hollow cup: Fengcai Technology - Dexterous hands: Zhaowei Electric - Linear joints: Hengli Hydraulic, Zhejiang Rongtai, Zhenyu Technology - Rotary joints: Lide Harmonic, Shuanghuan Transmission, Minshi Group, Keda Li [4][5]. NVIDIA's Ecosystem Development - NVIDIA is building a "CUDA ecosystem" for robotics, utilizing Cosmos (data generation), Isaac (simulation training), and GROOT (robotic foundational models) to attract developers and accelerate commercialization [4]. - The GROOT N1.7 model has been released, enhancing robotic operational capabilities and introducing reasoning modules, with the upcoming GROOT N2 aimed at achieving world-model-level physical understanding [4]. Robotics Training and Infrastructure - The report highlights the release of Isaac Lab 3.0, which features a new Newton physics engine and enhanced support for complex dexterous operation scenarios [4]. - The DGX™-AI training server platform integrates multiple high-end GPUs and is optimized for AI training, capable of forming GPU clusters to enhance training scale [4].

Group 1: Market Trends - New supply of private placement projects decreased, with 22 new projects added in the last two weeks, a decrease of 5 projects compared to the previous period[4] - The approval rate for projects remains stable at 100%, with 6 projects approved by the review committee, a decrease of 1 project[19] - The total number of projects in the normal review stage is 662, with 83 projects having passed the review and registration, remaining unchanged[4] Group 2: Fundraising and Pricing - The total fundraising amount for the 12 projects listed in the last two weeks is 6.799 billion yuan, a decrease of 67.20%[31] - The average base discount rate for competitive projects is 14.62%, up by 12.07 percentage points, while the market price discount rate averages 15.96%, an increase of 8.02 percentage points[31] - The average subscription rate for competitive projects is 62.04%, reflecting a 26.47 percentage point increase[42] Group 3: Project Analysis - North Self Technology plans to acquire 100% of Suike Intelligent for a maximum fundraising of 32 million yuan, with an estimated valuation of 140.3965 million yuan, resulting in a value increase rate of 413.16%[24] - Aobi Zhongguang-UW aims to raise up to 980 million yuan for AI vision and spatial perception technology projects, with a projected revenue growth rate exceeding 50% for 2024 and 2025[28] Group 4: Risk Factors - Risks include slower-than-expected review progress, fluctuations in secondary market stock prices, and changes in the pricing environment for private placements[4]

奥比中光科技集团股份有限公司 独立董事专门会议 2026 年第一次会议决议 一、独立董事专门会议召开情况 奥比中光科技集团股份有限公司（以下简称"公司"）独立董事专门会议 2026 年第一次会议通知于 2026 年 3 月 13 日以电子邮件等方式向全体独立董事发出， 会议于 2026 年 3 月 16 日以现场结合通讯表决方式召开。会议应出席独立董事 4 名，实际出席独立董事 4 名。经过半数独立董事推举，独立董事傅愉（Fu Yu） 先生召集并主持本次会议。 本次会议的召集、召开及表决程序符合《上市公司独立董事管理办法》等法 律法规、规范性文件和《奥比中光科技集团股份有限公司章程》（以下简称"《公 司章程》"）、《奥比中光科技集团股份有限公司独立董事制度》的相关规定，合法 有效。 综上，我们一致同意上述事项，并同意将本议案提交至公司第二届董事会第 二十四次会议审议。 （二）会议以 4 票同意，0 票反对，0 票弃权，审议通过了《关于公司设立 2025 年度向特定对象发行 A 股股票募集资金专用账户的议案》。 经全体与会独立董事审议：公司本次设立 2025 年度向特定对象发行 A 股股 票募集资金专用账户系用 ...

奥比中光科技集团股份有限公司 第二届董事会第二十四次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、董事会会议召开情况 奥比中光科技集团股份有限公司（以下简称"公司"）第二届董事会第二十四次 会议通知于 2026 年 3 月 13 日以电子邮件等方式向全体董事、高级管理人员发出，会 议于 2026 年 3 月 16 日在公司会议室以现场结合通讯表决方式召开。本次会议由公司 董事长黄源浩先生主持，会议应出席董事 10 名，实际出席董事 10 名（其中 3 名董事 以通讯表决方式出席会议），公司全体高级管理人员列席本次会议。本次会议的召集、 召开及表决程序符合《中华人民共和国公司法》等法律、行政法规、规范性文件和《奥 比中光科技集团股份有限公司章程》的规定，合法有效。 二、董事会会议审议情况 （一）会议以 10 票同意，0 票反对，0 票弃权，审议通过了《关于公司 2025 年度 向特定对象发行 A 股股票相关授权的议案》； 证券代码：688322 证券简称：奥比中光 公告编号：2026-009 本议案在提交 ...

Group 1 - The core viewpoint of the news is that the Sci-Tech Innovation Board (STAR Market) is witnessing the first batch of companies transitioning out of the growth tier, with significant revenue and profit growth expected for 2025 [2][3] - As of March 11, all companies on the STAR Market have disclosed their 2025 performance, projecting total revenue of 1.59 trillion yuan, a year-on-year increase of 10.3%, and net profit of 59.1 billion yuan, a year-on-year increase of 28.2% [2] - Six companies, including Cambricon and BeiGene, are expected to successfully turn profitable, with net profits ranging from 80 million yuan to 2.1 billion yuan, and are anticipated to remove the special "U" designation after the 2025 annual report [2][3] Group 2 - Among the six companies, BeiGene leads in revenue, expecting 2025 revenue of 38.205 billion yuan, a 40.4% increase, and a net profit of 1.422 billion yuan, driven by strong sales of its key products [3] - Cambricon achieved a revenue of 6.497 billion yuan in 2025, a substantial increase of 453.21%, marking its first annual profit since its IPO in 2020 [6][8] - Other companies like Orbbec and NIO also reported significant growth, with Orbbec's revenue reaching 941 million yuan (up 66.66%) and NIO's revenue at 2.726 billion yuan (up 108.93%) [8] Group 3 - The STAR Market's growth tier was established to support technology companies with significant breakthroughs and broad commercial prospects, particularly those that are not yet profitable at the time of listing [10] - Since the introduction of the "1+6" policy measures by the China Securities Regulatory Commission, several cutting-edge technology companies have accelerated their listing processes, with 39 companies now included in the growth tier [10] - The establishment of the growth tier enhances the market's inclusivity and attractiveness, catering to different risk preferences among investors [11]

Core Viewpoint - The first "delisting" wave of the Sci-Tech Innovation Board's growth tier marks a significant milestone in the capital market's service to technological innovation, indicating the effectiveness of the tiered mechanism from establishment to realization of results [3][10]. Summary by Sections Delisting Companies - A total of 39 companies in the Sci-Tech Innovation Board's growth tier have disclosed their 2025 performance data, with 6 companies successfully turning profitable and set to exit the growth tier [1][4]. - The companies include: - Zhongke Hanwuji (营业收入: 64.97 billion, 归母净利润: 20.59 billion) - Baiji Shenzhou (营业收入: 382.05 billion, 归母净利润: 14.22 billion) - Aobi Zhongguang (营业收入: 9.41 billion, 归母净利润: 1.27 billion) - Jingjin Electric (营业收入: 27.26 billion, 归母净利润: 1.62 billion) - Beixin Life (营业收入: 5.42 billion, 归母净利润: 0.81 billion) - Nuo Cheng Jianhua (预计营业收入: 23.65 billion, 预计归母净利润: 6.33 billion) [2][8]. Industry Impact - The delisting of these 6 companies reflects the successful implementation of the tiered mechanism, showcasing how technological breakthroughs can translate into market returns [5][11]. - The companies span key sectors such as innovative pharmaceuticals, high-end medical devices, semiconductors, and artificial intelligence [5][6]. Financial Performance - Zhongke Hanwuji reported a revenue increase of 453.21% to 64.97 billion, marking its first annual profit since its listing [6]. - Baiji Shenzhou achieved a revenue of 382.05 billion, a 40.4% increase, and turned a profit of 14.22 billion, recovering from a loss of 49.78 billion the previous year [7]. - Other companies also reported significant revenue and profit growth, indicating a trend of recovery and profitability in the growth tier [8]. Regulatory Framework - The growth tier's delisting process is governed by specific criteria, including a requirement for companies to achieve positive net profit and revenue thresholds [5][6]. - The establishment of the growth tier has provided a platform for unprofitable tech companies to access capital markets earlier, facilitating their transition from research and development to commercialization [11][12].

证券代码：688322 证券简称：奥比中光 公告编号：2026-008 奥比中光科技集团股份有限公司 关于 2025 年度向特定对象发行 A 股股票申请 收到中国证券监督管理委员会同意注册批复的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 奥比中光科技集团股份有限公司（以下简称"公司"）于近日收到中国证券 监督管理委员会出具的《关于同意奥比中光科技集团股份有限公司向特定对象发 行股票注册的批复》（证监许可〔2026〕394 号）（以下简称"批复文件"）， 具体内容如下： "一、同意你公司向特定对象发行股票的注册申请。 二、你公司本次发行应严格按照报送上海证券交易所的申报文件和发行方案 实施。 三、本批复自同意注册之日起 12 个月内有效。 四、自同意注册之日起至本次发行结束前，你公司如发生重大事项，应及时 报告上海证券交易所并按有关规定处理。" 公司董事会将按照上述批复文件和相关法律法规的要求以及公司股东会的 授权，在规定期限内办理本次向特定对象发行股票的相关事项，并及时履行信息 披露义务，敬请广大投资者注意投资风 ...

Summary of Key Takeaways from Orbbec's Management Discussion Company Overview - **Company**: Orbbec (688322.SS, Not Covered) - **Industry**: Robotics and AI Vision Technology - **Market Position**: Leading global provider of robot vision solutions with a significant market share in China, specializing in 3D sensing technology and vision cameras [3][4] Core Insights 1. **Robotic Business Growth**: - Orbbec has a high market share in the robot vision market in China, focusing on high-end robot models equipped with 3D vision sensors, which supports profitability [4] - Management anticipates growth driven by rising end applications of robots and an increasing number of new entrants in the robot vision market, indicating a growing market [4][9] 2. **Competitive Strengths**: - Established collaborations with leading global chipset suppliers, providing customers with vision modules based on diversified chipset platforms [5][8] - Rich intellectual property (IP) reserves in 3D sensing technology and in-house developed algorithms that enhance functionality and accuracy [5][8] 3. **Increased Dollar Content in Robots**: - The rising number of cameras per robot is driving higher dollar content, as more cameras enhance movement accuracy and functionality [9] - 3D sensing cameras provide more realistic spatial information compared to 2D products, meeting technical requirements for robots in both consumer and industrial applications [9] Additional Insights - **Positive Outlook**: Management holds a positive outlook on the robotics ecosystem, indicating confidence in Orbbec's growth trajectory [4] - **Industry Dynamics**: The increasing number of participants in the robot vision market reflects a healthy competitive landscape, suggesting robust future growth potential [4] This summary encapsulates the key points discussed during the management's presentation at the GS China Forum 2026, highlighting Orbbec's strategic advantages and market opportunities in the robotics sector.

Core Viewpoint - Six companies in the Sci-Tech Innovation Board's growth tier have turned profitable in 2025 and will be removed from this tier, marking a significant milestone for these previously unprofitable firms [1][3]. Group 1: Company Performance - Cambrian (688256) reported a revenue of 6.497 billion and a net profit of 2.059 billion in 2025 [1]. - BeiGene (688235) achieved a revenue of 38.2 billion and a net profit of 1.422 billion, reflecting a 40.4% increase in total revenue compared to the previous year [3][5]. - Orbbec (688322) generated a revenue of 941 million and a net profit of 127 million in 2025 [4][6]. - Jikong Electric (688280) reported a revenue of 2.726 billion and a net profit of 162 million [6]. - North Chip Life (688712) achieved a revenue of 542 million and a net profit of 81 million [8]. - Innovent Biologics (688428) projected a revenue of approximately 2.365 billion and a net profit of around 633 million for 2025, although it did not release a performance report by the specified date [9]. Group 2: Growth Tier Overview - The Sci-Tech Innovation Board's growth tier was established to support technology companies that are not profitable at the time of listing but have significant technological breakthroughs and commercial potential [1]. - As of March 6, 2025, there are 39 companies in the growth tier, with 32 existing and 7 newly registered [1].